Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – Here’s What Happened

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up before the market opened on Thursday . The stock had previously closed at $15.61, but opened at $16.15. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $15.70, with a volume of 738 shares trading hands.

Analyst Upgrades and Downgrades

TLX has been the subject of a number of recent analyst reports. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group began coverage on Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They set a “buy” rating and a $21.00 target price on the stock.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The firm has a 50 day simple moving average of $15.64.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.